American Diabetes Association
Browse

Consensus Considerations and Good Practice Points for use of Continuous Glucose Monitoring Systems in Hospital Settings

Download (155.87 kB)
figure
posted on 2024-10-25, 00:10 authored by Julie L. V. Shaw, Raveendhara R. Bannuru, Nuha El Sayed, Guido Freckmann, Anna K. Füzéry, Angela W.S. Fung, Jeremy Gilbert, Yun Huang, Nichole Korpi-Steiner, Samantha Logan, Rebecca Longo, Dylan MacKay, Lisa Maks, Stefan Pleus, Kendall Rogers, Jane Seley, Zachary Taxin, Fiona Thompson-Hutchison, Nicole V. Tolan, Nam K. Tran, Allison A. Venner

Continuous glucose monitoring (CGM) systems provide frequent glucose measurements in interstitial fluid and have been used widely in ambulatory settings for diabetes management. During the COVID-19 pandemic, regulators in the United States and Canada temporarily allowed for CGM systems to be used in hospitals with the aim of reducing healthcare professional COVID-19 exposure and limiting use of personal protective equipment. As such, studies on hospital CGM system use have been possible. With improved sensor accuracy, there is increased interest in CGM usage for diabetes management in hospitals. Laboratorians and healthcare professionals must determine how to integrate CGM usage into practice. This consensus guidance document aims to provide an update on the application of CGM systems in hospital, with insights and opinions from laboratory medicine, endocrinology, and nursing.

Funding

American Diabetes Association Association for Diagnostics and Laboratory Medicine Canadian Society of Clinical Chemists Diabetes Canada

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC